Please Note: There is no Medicare information on our corporate website. Please select a specific contract in the 'Search Within' box for Medicare related information.
© 2021 Palmetto GBA, LLC
We frequently update our articles to reflect the latest changes and updates to Medicare, and strongly recommend you visit this article at link below to confirm you have the latest version.
Printed Date: 9/22/2015
For many years it has been our practice to send Provider Enrollment communications via email. Effective November 13, 2017, our email communication process will be streamlined with the implementation of new email addresses specific to Provider Enrollment Additional Development Requests (ADRs) and final application completion letters.
ADR emails will be sent from the following addresses based on whether the application submitted is for Part A/HHH or B.
The subject line of the ADR email will state your 'DCN # - Medicare Enrollment ADR'. Please ensure that when responding to ADR emails you reply ALL and do not alter the subject line. This will ensure the appropriate handling of your application.
Provider Enrollment Completion letter will be sent from NOREPLYJMPROVIDERENROLLMENT@PALMETTOGBA.COM. The subject line will state your 'DCN Number-Completion Letter'. This is a non-monitored box and any replies will not be received. If you have any questions regarding your completion letter, you may follow the instructions in the letter or contact the analyst at the contact information on the letter.
We value your opinion and want to provide the highest-quality and most relevant Medicare knowledge possible. Please let us know if this article was helpful.
It didn't answer my question
This article was helpful
We’re glad we could help you today and appreciate your feedback. When you rate our articles as most helpful, we know that we are on the right track for providing you with important news and information.
We're sorry this article didn't help you today. We'll use your feedback to review this article to try to revise or expand it. Contact us with more feedback or a question on this topic.
Last Updated: 02/07/2018
We've recently uppgraded our website and it looks you're trying to access an old link. Please select an option below.
Attempt to load this page on new site
Go to Home page
Go to Contact Us page
View a related article: